DC Field | Value | Language |
---|---|---|
dc.contributor.author | Veinbergs, I | ko |
dc.contributor.author | Mante, M | ko |
dc.contributor.author | Jung, MW | ko |
dc.contributor.author | Van Uden, E | ko |
dc.contributor.author | Masliah, E | ko |
dc.date.accessioned | 2013-03-03T09:16:03Z | - |
dc.date.available | 2013-03-03T09:16:03Z | - |
dc.date.created | 2013-02-20 | - |
dc.date.created | 2013-02-20 | - |
dc.date.issued | 1999-04 | - |
dc.identifier.citation | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY BIOLOGICAL PSYCHIATRY, v.23, no.3, pp.519 - 531 | - |
dc.identifier.issn | 0278-5846 | - |
dc.identifier.uri | http://hdl.handle.net/10203/78155 | - |
dc.description.abstract | 1. Aged apoE-deficient mice and age-matched controls were tested for cognitive alterations in the Morris water maze. 2. Water maze results were correlated with in vivo electrophysiology and expression of the synaptic protein synaptotagmin (p65). 3. Compared to age-matched controls, apolipoprotein E-deficient mice displayed significant performance impairment accompanied by in vivo electrophysiological alterations in the dentate gyrus. 4. Apolipoprotein B-deficient mice also showed a significant increase in the synaptic protein, synaptotagmin, a synaptic calcium sensor involved in neurotransmitter release. 5. Cognitive impairments in these animals may be associated with decreased synaptic excitability in hippocampal neurons and the regulatory role of apolipoprotein E in synaptic function might be mediated by modulation of the expression of calcium sensor proteins. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | ALZHEIMERS-DISEASE | - |
dc.subject | CHOLINERGIC IMPAIRMENTS | - |
dc.subject | VESICLE PROTEIN | - |
dc.subject | NEURODEGENERATION | - |
dc.subject | INJURY | - |
dc.subject | BRAIN | - |
dc.subject | APOE | - |
dc.title | Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice | - |
dc.type | Article | - |
dc.identifier.wosid | 000080358600012 | - |
dc.identifier.scopusid | 2-s2.0-0006237627 | - |
dc.type.rims | ART | - |
dc.citation.volume | 23 | - |
dc.citation.issue | 3 | - |
dc.citation.beginningpage | 519 | - |
dc.citation.endingpage | 531 | - |
dc.citation.publicationname | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY BIOLOGICAL PSYCHIATRY | - |
dc.identifier.doi | 10.1016/S0278-5846(99)00013-5 | - |
dc.contributor.localauthor | Jung, MW | - |
dc.contributor.nonIdAuthor | Veinbergs, I | - |
dc.contributor.nonIdAuthor | Mante, M | - |
dc.contributor.nonIdAuthor | Van Uden, E | - |
dc.contributor.nonIdAuthor | Masliah, E | - |
dc.type.journalArticle | Review | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | apolipoprotein E | - |
dc.subject.keywordAuthor | calcium homeostasis | - |
dc.subject.keywordAuthor | electrophysiology | - |
dc.subject.keywordAuthor | Morris water maze | - |
dc.subject.keywordAuthor | synaptotagmin. | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | CHOLINERGIC IMPAIRMENTS | - |
dc.subject.keywordPlus | VESICLE PROTEIN | - |
dc.subject.keywordPlus | NEURODEGENERATION | - |
dc.subject.keywordPlus | INJURY | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordPlus | APOE | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.